Insight Series

October 20, 2023 | 11:00 AM CT

This session will illustrate recent advances in our understanding of how pathogen recognition and consequent innate immune signaling may impact non-viral delivery of nucleic acids for better or for worse. 

Speakers 

• Moderators: Federico Mingozzi, PhD - Spark Therapeutics, and Stefan Radtke, PhD - Fred Hutchinson Cancer Research Center

• Kate Fitzgerald, PhD - University of Massachusetts Chan Medical School
  Toll-Like receptor signaling, innate nucleic acid sensors, and the innate immune response

• Marina Dobrovolskaia, PhD - Frederick National Laboratory for Cancer Research
  Immunological Properties of LNPs & Nucleic Acid-Based APIs

• Pedro Cejas, PhD - Spark Therapeutics
  Overcoming barriers to safe and efficient non-viral delivery of DNA

Watch on demand

More ASGCT Insights

Register for more sessions during ASGCT Insights Week, Oct. 16-20. Members and registrants can watch on demand!

• Oct. 16: Best of ASGCT: Annual Meetings Recent Top Abstracts Revisited

• Oct. 17: Risk Assessment of Lentiviral and AAV Gene Therapy Vectors

• Oct. 18: Risk Assessment for Gene Editing Technologies and Outcomes

• Oct. 19: Treating Genetic Diseases Prior to Birth from Stem Cells to Gene Delivery